Skip to main content

Table 1 Baseline and characteristics

From: Heparin-binding protein measurement improves the prediction of myocardial injury-related cardiogenic shock

Variable

Control

(n = 620)

MIRCS

(n = 172)

P value

Age (year)

61.25 ± 13.16

60.45 ± 8.94

0.45

Gender (male)

282,45.48%

85,49.42%

0.39

Weight (kg)

64.72 ± 11.82

66.04 ± 14.23

0.22

Preoperative LVEF (%)

49.96 ± 10.60

50.45 ± 12.94

0.62

Preoperative LVDd (cm)

5.78 ± 0.85

5.79 ± 1.17

0.91

Preoperative cTnT (ug/L)

0.02 ± 0.02

0.02 ± 0.02

0.39

EuroSCORE

4.82 ± 3.45

4.39 ± 3.29

0.13

Previous medical history

 Myocardial infarction

3, 0.48%

0

0.36

 Diabetes Mellitus (n,%)

45,7.26%

20,11.63%

0.07

 Hypertension (n,%)

336,54.19%

79, 45.93%

0.02

 Chronic Renal Failure (n,%)

0

3,1.74%

0.02

 Liver diseases (n,%)

51, 8.23%

13,7.56%

0.75

 Previous cardiac operation (n,%)

34,5.48%

6, 3.49%

0.27

 Immunological diseases (n,%)

6, 0.97%

0

0.19

 Atrial fibrillation (n,%)

334, 53.87%

68, 39.53%

< 0.01

 Peripheral vascular diseases (n,%)

13, 2.10%

0

0.05

 Blood products transfusion (n,%)

0

0

 Heavily smoking (n,%)

72,11.61%

0

< 0.01

 Excessive alcohol (n,%)

24, 3.87%

3,1.74%

0.24

Type of cardiac surgery (n,%)

  

0.02

 AVR

21,3.39%

0

 

 MVR

340, 54.84%

82, 47.67%

 

 AVR + MVR

202, 32.58%

69, 40.12%

 

 Aortic operation + AVR

57, 9.19%

21, 12.21%

 

Intraoperative AF ablation (n,%)

306, 49.35%

66, 38.37%

0.01

CPB time (minutes)

161.13 ± 74.83

169.86 ± 51.57

0.08

ACC time (minutes)

119.84 ± 65.42

127.51 ± 46.44

0.09

  1. cTnT Serum cardiac troponin T, MVR Mitral valve replacement, MIRCS myocardial injury-related cardiogenic shock, CPB Cardiopulmonary Bypass, AVR Aortic valve replacement, LVEF Left Ventricular Ejection Fraction, LVDd Left ventricular end diastolic diameter